Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Inovio Stock Plunged Today

TheMotleyFool

0 0

Shares of Inovio Pharmaceuticals (NASDAQ: INO) declined on Tuesday after investment bank Roth Capital Partners released a bearish report on the biotechnology company. As of 12:45 p.m. EST, Inovio's stock was down 8.5%.

Roth Capital analyst Jonathan Aschoff slashed his rating on Inovio from neutral to sell. He sees its share price falling more than 30% to $8 amid intensifying competition from the likes of Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA).

Inovio shareholders could suffer steep losses, according to a Roth Capital analyst. Image source: Getty Images.

Source Fool.com

Like: 0

INO

Share